HBC January 2017 News Bulletin

Tuesday, January 24, 2017

Looking ahead…looking ahead

  1. Travel Reimbursement Requests:airplane 

On January 9, 2017, an announcement to all staff and faculty was issued from the comptroller’s office indicating that the 60-day limit travel reimbursement policy will be enforced starting March 1, 2017 for travel that ended December 31, 2016 or later.  Therefore, make sure to submit any travel expense receipts within 60 days of your return to avoid having your travel reimbursement treated as a taxable fringe benefit.

  1. 2) H-1B policy change:H-1B 

Please note that KU recently changed its policy concerning H-1B visa applications.  The standard H-1B applications filed by the International Program Office are now for a three-year stay period rather than for a one-year stay period with yearly extensions.  This change was implemented because it currently takes nearly a year to obtain an H-1B visa (12+ weeks for the U.S. Dept. of Labor wage determinations and 8+ months for the USCIS to process the H-1B application).  Therefore, the process of obtaining an H-1B had to start nearly a year in advance to be completed on time and had to re-start almost immediately again to obtain an extension for the following year.  This put undue burden on the KU International Program Office and made it nearly impossible for the beneficiary to travel outside the U.S. as they were not allowed to travel while their case was being reviewed.  One disadvantage to this new policy is if an employer chooses to end the visa holder’s employment before the three-year approved visa ends, that employer must pay for the employee’s return transportation costs home.   However, this cost is offset by not paying the yearly H-1B extension application fee, which increased in December 2016.

 

NIH processes modification for 2017

  1. Final RPPR replaces FPR

As of January 1, 2017, NIH has retired and will no longer accept the Final Progress Report (FPR) old format (NOT-OD-17-022).  The FPR will be replaced by a new report, the Final Research Performance Progress Report (Final RPPR or F-RPPR), which has a format similar to the current annual\interim RPPR.  This step was taken as part of the federal government transition to standard reporting for all federally funded research awards or research related activities.  The final step of this transition, which is currently under consideration, will be a modification of the final reporting process for those who seek a competing renewal.  A notice will be issued in the near future to indicate when this last step will take effect and how it will work.

  1. Update to NIH Application Guide

An update to the NIH Application Guide, issued at the end of last year, will affect all award applications submitted on or after January 25, 2017.  Two important changes are to be kept in mind:

  1.  Only specific materials may be included in the appendix section of the proposal (NOT-OD-16-129) unless specified otherwise in the Funding Opportunity Announcement (FOA).  Applications submitted with appendix materials other than those listed below will be withdrawn and not reviewed.  The allowed materials for all applications are:
  • Blank informed consent/assent forms
  • Blank surveys, questionnaires, data collection instruments
  • FOA specified items: applications submitted without those appendix materials will be considered incomplete and will not be reviewed.

For applications proposing clinical trials:

  • Clinical trial protocols
  • Investigator’s brochure from Investigational New Drug as appropriate.
  1. The allowable post-submission materials that can be submitted due to unforeseen events after submission but prior to initial review has been simplified.  To review the list please refer to NIH Guide Notice NOT-OD-16-130

 

HBC 2017 Sciences Talks reminder

The HBC invites you to attend the HBC Science Talks held on February 17, 2017, at 1:30 pm in the Simons Auditorium.  For those who wish to share their research by participating in the afternoon poster session, please submit your abstract by 8:00 am on February 14 using our online form.



Grant Submission Deadlines

August 12, 2020
NIH Standard deadline for R13, U13 – new, renewal, resubmission, revision.

September 8, 2020
DoD Breast Cancer Breakthrough Award Levels 1 and 2   and Era of Hope Scholar Award – Pre-Application deadline (Full Application deadline: September 22)..

Recent Awards

Brandon DeKosky, Assistant Professor, Departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering, was awarded $107,724 by Columbia University in the City of NY for the project entitled: “Columbia University’s Proposed Response to the New Coronavirus Outbreak.”  He was also awarded $75,000 by the Mercatus Center for the project entitled: “COVID-19 Fast Grants.”

Paulyn Cartwright, Professor, Department of Ecology & Evolutionary Biology, was awarded $1,573,996 by the National Institutes of Health for her project entitled “MARC for The University of Kansas.”

David Davido, Professor, Department of Molecular Biosciences, was awarded $405,301 by the National Institutes of Health for his project entitled: “Identifying functional targets of HSV-1 ICP0-directed degradation.”

Michael Hageman, Distinguished Professor, Department of pharmaceutical chemistry, was awarded $20,000 by the J.R. & Inez Jay Funds for his project entitled: “Translation of Injectable-to-Oral Peptide Pharmacotherapy: Application of E-Cadherin Binding Peptides as Oral Membrane Permeation Enhancers.”

Jennifer Robinson, Assistant Professor, Department of Chemical and Petroleum Engineering, was awarded $78,210 by the KU Medical Center Research Institute for her project entitled “Behavior of adipose stem cells in 2D and 3D in a wound healing context.”

Frank Schoenen, Associate Research Professor, Higuchi Biosciences Center, was awarded $20,000 by the J.R. & Inez Jay Funds for his project entitled: “Design  synthesis  analytical characterization  eAMDE formulation sub-chronic MTD and in vivo PK of ML329 Prodrugs.”

Joanna Slusky, Associate Professor, Department of Molecular Biosciences, was awarded $37,875 by the KU Medical Center Research Institute as mentor for Jimmy Budiardjo for the project entitled “Designing peptide-based inhibitors of bacterial efflux pumps.”

Jingxin Wang, Assistant Professor, Department of Medicinal Chemistry, was awarded $20,000 by the J.R. & Inez Jay Funds for his project entitled: “Mechanistic study of RNA splicing modulation by small molecules.”

One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
—ALA
5th nationwide for service to veterans —"Best for Vets: Colleges," Military Times
KU Today